Compare Glenmark Pharma with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA GLAND PHARMA GLENMARK PHARMA/
GLAND PHARMA
 
P/E (TTM) x 14.0 - - View Chart
P/BV x 2.0 10.7 19.0% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 GLENMARK PHARMA   GLAND PHARMA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-21
GLAND PHARMA
Mar-21
GLENMARK PHARMA/
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs5732,784 20.6%   
Low Rs1951,701 11.5%   
Sales per share (Unadj.) Rs387.8211.7 183.2%  
Earnings per share (Unadj.) Rs34.460.9 56.4%  
Cash flow per share (Unadj.) Rs50.167.0 74.8%  
Dividends per share (Unadj.) Rs2.500-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs249.6359.3 69.5%  
Shares outstanding (eoy) m282.17163.59 172.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.010.6 9.3%   
Avg P/E ratio x11.236.8 30.4%  
P/CF ratio (eoy) x7.733.5 22.9%  
Price / Book Value ratio x1.56.2 24.6%  
Dividend payout %7.30-   
Avg Mkt Cap Rs m108,353366,894 29.5%   
No. of employees `000NANA-   
Total wages/salary Rs m23,4373,114 752.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m109,43934,629 316.0%  
Other income Rs m5021,348 37.3%   
Total revenues Rs m109,94135,977 305.6%   
Gross profit Rs m21,28913,022 163.5%  
Depreciation Rs m4,436988 449.0%   
Interest Rs m3,53134 10,352.2%   
Profit before tax Rs m13,82513,348 103.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,1243,378 122.1%   
Profit after tax Rs m9,7019,970 97.3%  
Gross profit margin %19.537.6 51.7%  
Effective tax rate %29.825.3 117.9%   
Net profit margin %8.928.8 30.8%  
BALANCE SHEET DATA
Current assets Rs m73,59651,236 143.6%   
Current liabilities Rs m42,0105,125 819.7%   
Net working cap to sales %28.9133.2 21.7%  
Current ratio x1.810.0 17.5%  
Inventory Days Days78 78.2%  
Debtors Days Days8671 121.3%  
Net fixed assets Rs m67,09313,724 488.9%   
Share capital Rs m282164 172.5%   
"Free" reserves Rs m70,14858,615 119.7%   
Net worth Rs m70,43058,778 119.8%   
Long term debt Rs m38,88839 98,851.4%   
Total assets Rs m140,68964,961 216.6%  
Interest coverage x4.9392.3 1.3%   
Debt to equity ratio x0.60 82,497.7%  
Sales to assets ratio x0.80.5 145.9%   
Return on assets %9.415.4 61.1%  
Return on equity %13.817.0 81.2%  
Return on capital %15.922.8 69.8%  
Exports to sales %083.8 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA29,021 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m35,75329,021 123.2%   
Fx outflow Rs m12,02316,878 71.2%   
Net fx Rs m23,72912,142 195.4%   
CASH FLOW
From Operations Rs m11,3126,049 187.0%  
From Investments Rs m-6,752-15,240 44.3%  
From Financial Activity Rs m-4,41812,385 -35.7%  
Net Cashflow Rs m2783,230 8.6%  

Share Holding

Indian Promoters % 46.5 0.0 -  
Foreign collaborators % 0.0 58.1 -  
Indian inst/Mut Fund % 41.2 22.5 183.0%  
FIIs % 34.4 10.4 329.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.5 41.9 127.8%  
Shareholders   85,475 98,203 87.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   DISHMAN PHARMA  BROOKS LAB  ZIM LABORATORIES  GRANULES INDIA  BERYL DRUGS  



Today's Market

Sensex Ends Above 60,000-Mark, Nifty Tops 17,850; Asian Paints & Eicher Motors Climb 3%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 20.7% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 20.7% YoY). Sales on the other hand came in at Rs 30 bn (up 26.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 132.5% (Quarterly Result Update)

Sep 1, 2020 | Updated on Sep 1, 2020

For the quarter ended June 2020, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 132.5% YoY). Sales on the other hand came in at Rs 23 bn (up 0.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC(Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

Top Small Caps to Buy Now(Views On News)

Sep 18, 2021

Rahul Shah on why he would invest in these unusual 20 small cap stocks

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Sep 24, 2021 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 8-QTR ANALYSIS

COMPARE GLENMARK PHARMA WITH

MARKET STATS